pharyng
associ
inflamm
pharynx
one
common
reason
patient
seek
health
care
profession
advic
acut
pharyng
predominantli
caus
viral
upper
respiratori
tract
infect
common
cold
usual
selflimit
symptom
sore
throat
last
day
despit
antibiot
still
frequent
inappropri
use
treatment
pharyng
even
though
patient
consult
doctor
often
primarili
seek
reassur
symptomat
relief
antibiot
ineffect
virus
caus
case
offer
symptomat
relief
inappropri
antibiot
prescript
contribut
antimicrobi
resist
seriou
threat
global
public
health
consequ
need
nonantibiot
treatment
broad
antiinfect
effect
meet
patient
need
relief
symptom
antisept
class
antimicrobi
agent
kill
via
physic
action
bacteria
addit
bactericid
activ
antisept
amylmetacresol
amc
alcohol
dcba
shown
antivir
effect
vitro
anestheticlik
effect
establish
benefit
provid
symptomat
relief
pain
bacteri
infect
contribut
pharyng
case
adult
common
bacteri
caus
acut
pharyng
reason
legitim
antibiot
prescrib
prevent
complic
group
streptococcu
gabh
streptococcu
pyogen
respons
case
children
less
frequent
adult
case
rare
result
complic
number
bacteria
also
implic
infect
throat
may
present
complic
patholog
repres
either
opportunist
infect
underli
medic
condit
less
common
speci
recov
patient
present
symptom
pharyng
clinic
diagnosi
pharyng
includ
fusobacterium
necrophorum
describ
recent
studi
true
pathogen
rather
colon
oropharynx
streptococcu
dysgalactia
subspeci
equisimili
caus
sever
recurr
pharyng
although
insuffici
evid
role
dysgalactia
advers
outcom
moraxella
catarrhali
frequent
isol
patient
pharyng
combin
pyogen
may
signific
consid
separ
studi
demonstr
catarrhali
potenti
adhes
pyogen
nasopharyng
epithelium
bacteria
cultur
patient
pharyng
includ
haemophilu
influenza
arcanobacterium
haemolyticum
opportunist
pathogen
staphylococcu
aureu
although
clinic
signific
aureu
associ
known
patient
diagnos
tonsil
f
necrophorum
appear
clinic
import
speci
preval
significantli
higher
subject
clinic
tonsil
compar
subject
without
tonsil
aureu
also
identifi
common
caus
tonsil
common
pathogen
isol
patient
undergo
tonsillectomi
due
recurr
tonsil
h
influenza
similarli
recov
patient
tonsil
although
clinic
signific
current
unknown
nonantibiot
antimicrobi
treatment
could
potenti
benefit
patient
bacteri
pharyng
offer
antimicrobi
activ
also
symptomat
relief
vitro
activ
lozeng
formul
previous
investig
pyogen
aureu
studi
vitro
bactericid
activ
amcdcba
lozeng
broader
rang
potenti
pathogen
oropharyng
bacteria
assess
evalu
potenti
vivo
action
lozeng
organ
associ
pharyng
bactericid
assay
amc
bactericid
assay
perform
follow
protocol
similar
clinic
laboratori
standard
institut
approv
guidelin
specif
inoculum
cultur
prepar
challeng
organ
give
approxim
popul
colonyform
unit
cfu
ml
salin
sodium
chlorid
fisher
scientif
one
inoculum
suspens
prepar
replic
test
test
sampl
ml
prepar
inocul
ml
inoculum
suspens
solut
vortex
thoroughli
mix
test
contact
time
consist
time
lozeng
take
dissolv
mouth
test
organ
evid
bactericid
activ
record
time
point
tabl
figur
test
control
count
demonstr
test
method
media
affect
surviv
organ
pyogen
h
influenza
haemolyticum
f
necrophorum
decreas
cfuml
minut
exceed
log
decreas
wherea
greater
log
reduct
record
minut
dysgalactia
catarrhali
minut
aureu
addit
time
point
sd
tabl
replic
small
log
cfuml
indic
consist
reproduc
observ
result
demonstr
amcdcba
lozeng
exhibit
broad
bactericid
activ
rang
organ
implic
pharyng
rapid
activ
observ
consist
time
taken
lozeng
dissolv
mouth
test
organ
evid
bactericid
activ
amcdcba
lozeng
record
time
point
particular
interest
robust
bactericid
activ
pyogen
frequent
caus
bacteri
pharyng
reduct
exceed
achiev
minut
pyogen
h
influenza
haemolyticum
f
necrophorum
minut
dysgalactia
catarrhali
minut
aureu
bactericid
activ
amcdcba
lozeng
within
period
import
consist
durat
lozeng
remain
mouth
furthermor
activ
ingredi
also
test
expect
concentr
achiev
lozeng
dissolv
mouth
assum
volum
ml
saliva
data
gener
studi
support
expand
upon
previous
publish
observ
provid
evid
effect
broader
rang
bacteri
speci
vitro
condit
includ
knowledg
clinic
patholog
pharyng
continu
evolv
repres
either
opportunist
infect
underli
medic
condit
data
likewis
complement
recent
studi
show
vitro
viricid
effect
lozeng
contain
amcdcba
activ
ingredi
free
substanc
parainfluenza
viru
type
cytomegaloviru
respiratori
syncyti
viru
influenza
sever
acut
respiratori
syndrom
coronaviru
addit
antimicrobi
activ
amc
dcba
proven
provid
relief
symptom
pharyng
particularli
sore
throat
like
demonstr
local
anestheticlik
action
voltageg
neuron
sodium
channel
therefor
may
benefit
patient
present
either
bacteri
viral
pharyng
furthermor
reliev
symptom
manag
patient
expect
number
instanc
inappropri
antibiot
prescrib
viral
pharyng
may
reduc
limit
studi
observ
perform
vitro
therefor
fulli
reflect
environ
throat
exampl
throat
may
bactericid
action
amcdcba
lozeng
pharyng
contain
multipl
microorgan
wherea
studi
test
bactericid
activ
organ
isol
role
patient
immun
system
swallow
action
antimicrobi
activ
lozeng
activ
ingredi
also
determin
use
vitro
methodolog
howev
incid
bacteria
relevantli
low
gener
popul
therefor
studi
bactericid
activ
amcdcba
vivo
challeng
consequ
vitro
approach
advantag
allow
rapid
gener
robust
data
multipl
organ
simultan
use
evalu
potenti
amcdcba
efficaci
vivo
data
show
amcdcba
lozeng
demonstr
bactericid
activ
test
organ
repres
broad
rang
bacteri
cell
structur
minut
achiev
greater
kill
test
organ
within
minut
consist
durat
lozeng
remain
mouth
therefor
patient
uncompl
bacteri
pharyng
includ
take
antibiot
lowrisk
popul
without
addit
risk
factor
may
benefit
antisept
action
amcdcba
rang
bacteri
speci
associ
pharyng
case
pharyng
requir
antibiot
typic
selflimit
often
viral
origin
therefor
overthecount
antisept
like
amcdcba
may
appropri
unless
condit
deterior
streptococc
infect
diagnos
data
gener
analyz
studi
includ
manuscript
submit
manuscript
wwwdovepresscom
submit
manuscript
http
wwwdovepresscominternationaljournalofgeneralmedicinejourn
intern
journal
gener
medicin
intern
peerreview
openaccess
journal
focus
gener
intern
medicin
pathogenesi
epidemiolog
diagnosi
monitor
treatment
protocol
journal
character
rapid
report
review
origin
research
clinic
studi
across
diseas
area
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
visit
http
wwwdovepresscomtestimonialsphp
read
real
quot
publish
author
